Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Functional and structural analysis of the Lyb-2 system].

T Ashida1, I Kawabata, H Yakura

  • 12nd Dept. of Pathology, Asahikawa Medical College.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.

European journal of cancer (Oxford, England : 1990)·2018
Same author

Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.

Bone marrow transplantation·2016
Same author

Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours.

European journal of cancer (Oxford, England : 1990)·2014
Same author

Effect of the Pt buffer layer on perpendicular exchange bias based on collinear/non-collinear coupling in a Cr<sub>2</sub>O<sub>3</sub>/Co<sub>3</sub>Pt interface.

Journal of applied physics·2013
Same author

The Lyb-2 phenotype of hemolytic PFC.

Immunogenetics·2012
Same author

Crystal structures of the cyclic oligoesters from 6,8-dioxabicyclo[3.2.1]octan-7-one. 3. The cyclic pentamer.

Journal of the American Chemical Society·2011

The Lyb-2 molecule plays a key role in B cell activation by B cell stimulatory factor-1 (BSF-1). This study reveals Lyb-2

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Context:

  • The Lyb-2 molecule is a B cell-specific surface protein in mice, crucial for early B cell differentiation.
  • B cell stimulatory factor-1 (BSF-1), also known as interleukin-4, mediates key B cell activation processes.
  • Understanding Lyb-2's function and structure is vital for elucidating BSF-1-initiated B cell regulatory mechanisms.

Purpose:

  • To define the functional role of the Lyb-2 molecule in B cell activation.
  • To characterize the structural features of the Lyb-2 molecule.
  • To investigate Lyb-2's involvement in BSF-1-mediated signaling pathways.

Summary:

  • Lyb-2 antibody inhibits BSF-1-mediated activation, including Ia antigen induction and IgG1 production in lipopolysaccharide-activated B cells, indicating Lyb-2 participates in BSF-1 receptor signaling.

Related Experiment Videos

  • Structural analysis reveals Lyb-2 is not a 45 kDa monomer but consists of 45 kDa and 105 kDa components.
  • Further analysis shows Lyb-2 exists as a disulfide-bonded heterodimer (45 kDa and 105 kDa) and a 45 kDa homodimer on the B cell surface.

    • Impact:

    • This research clarifies Lyb-2's role in B cell signaling and provides novel structural insights.
    • The findings contribute to a deeper understanding of B cell differentiation and activation pathways.
    • Further investigation is needed to correlate Lyb-2's unique structure with its functional expression.